Journal article · 2026

Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies

Lin Huan, Hao Ran, Shiyi Wang, Xiaoping Zhang, Bing Yang, Yang He, Dandan Liu, Chenpeng Su, Chuan Chen, Xiaoqian Chen, Kezhen Ye, Liang Tian and 2 more

Cancer Research, 86(7_Supplement), 5591 · Published 3 April 2026 · DOI 10.1158/1538-7445.am2026-5591

View at the publisherCite this paper

In brief

“Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies” is a 2026 journal article by Lin Huan and 13 co-authors, published in Cancer Research. OpenAlex counts 0 citations as of 20 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
14

Abstract

Rationale B cells and autoantibodies drive the progression of autoimmune diseases. Targeting B cells or plasma cells alone is often insufficient to eliminate both pathogenic B cells and autoantibody. Here, we generated HXN-1031, a novel trispecific T cell engager (TCE), simultaneously targeting CD19 and BCMA. Methods: Affinity, cell-binding and cytotoxicity were evaluated in vitro. In… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Huan, L., Ran, H., Wang, S., Zhang, X., Yang, B., He, Y., Liu, D., Su, C., Chen, C., Chen, X., Ye, K., Tian, L., Peng, J., & Zhu, Z. (2026). Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies. Cancer Research, 86(7_Supplement), 5591. https://doi.org/10.1158/1538-7445.am2026-5591

MLA 9

Huan, Lin, et al. “Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies.” Cancer Research, vol. 86, no. 7_Supplement, 2026, p. 5591. https://doi.org/10.1158/1538-7445.am2026-5591.

Chicago

Huan, Lin, Hao Ran, Shiyi Wang, Xiaoping Zhang, Bing Yang, Yang He, Dandan Liu, et al. 2026. “Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies.” Cancer Research 86 (7_Supplement): 5591. https://doi.org/10.1158/1538-7445.am2026-5591.

Harvard

Huan, L. et al. (2026) ‘Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies’, Cancer Research, 86(7_Supplement), p. 5591. doi:10.1158/1538-7445.am2026-5591.

IEEE

L. Huan et al., “Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies,” Cancer Research, vol. 86, no. 7_Supplement, p. 5591, 2026, doi: 10.1158/1538-7445.am2026-5591.

BibTeX

@article{huan2026abstract,
  title     = {{Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies}},
  author    = {Huan, Lin and Ran, Hao and Wang, Shiyi and Zhang, Xiaoping and Yang, Bing and He, Yang and Liu, Dandan and Su, Chenpeng and Chen, Chuan and Chen, Xiaoqian and Ye, Kezhen and Tian, Liang and Peng, Jian and Zhu, Zhenping},
  journal   = {Cancer Research},
  year      = {2026},
  volume    = {86},
  number    = {7_Supplement},
  pages     = {5591},
  doi       = {10.1158/1538-7445.am2026-5591},
  url       = {https://doi.org/10.1158/1538-7445.am2026-5591}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • trispecific T cell engager
  • CD19
  • BCMA
  • B-cell depletion
  • plasma cell depletion
  • autoimmune disease
  • B-cell malignancies
  • autoantibodies

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Huan, L., Ran, H., Wang, S., Zhang, X., Yang, B., He, Y., Liu, D., Su, C., Chen, C., Chen, X., Ye, K., Tian, L., Peng, J., & Zhu, Z. (2026). Abstract 5591: Development of a novel anti-CD19 x BCMA dual targeted T cell engager for the treatment of autoimmune diseases and B cell malignancies. Cancer Research, 86(7_Supplement), 5591. https://doi.org/10.1158/1538-7445.am2026-5591

How many times has this paper been cited?

0 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Lin Huan, Hao Ran, Shiyi Wang, Xiaoping Zhang, Bing Yang, Yang He, Dandan Liu, Chenpeng Su, Chuan Chen, Xiaoqian Chen, Kezhen Ye, Liang Tian and 2 more.

What is the DOI of this paper?

10.1158/1538-7445.am2026-5591, permanently at https://doi.org/10.1158/1538-7445.am2026-5591. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.